Singapore, Intermediary

Changechevron_right
menu
search
search

Private biotech investing in 2025

Nilesh Kumar, PhD, Head of Biotech Private Investments
February 2025
4 min view
2026-02-28
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
nilesh-kumar

The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.

Nilesh Kumar, head of biotech private investing, shares his outlook for 2025, weighing headline risk against biotech venture capital's potential tailwinds.

Expert

Related insights

Showing 1 of 1 Insights Posts
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private market update

Continue reading
event April 2025
Video
2026-04-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Read next